BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31366084)

  • 1. Bioluminescence Resonance Energy Transfer Based G Protein-Activation Assay to Probe Duration of Antagonism at the Histamine H
    Mocking TAM; Buzink MCML; Leurs R; Vischer HF
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of the activation of the histamine H3 receptor (H3R) using novel fluorescence resonance energy transfer biosensors and their potential application to the study of H3R pharmacology.
    Liu Y; Zeng H; Pediani JD; Ward RJ; Chen LY; Wu N; Ma L; Tang M; Yang Y; An S; Guo XX; Hao Q; Xu TR
    FEBS J; 2018 Jun; 285(12):2319-2336. PubMed ID: 29701013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H
    Mocking TAM; Verweij EWE; Vischer HF; Leurs R
    Mol Pharmacol; 2018 Dec; 94(6):1371-1381. PubMed ID: 30249614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H
    Rosier N; Grätz L; Schihada H; Möller J; Işbilir A; Humphrys LJ; Nagl M; Seibel U; Lohse MJ; Pockes S
    J Med Chem; 2021 Aug; 64(15):11695-11708. PubMed ID: 34309390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRET Analysis of GPCR Dimers in Neurons and Non-Neuronal Cells: Evidence for Inactive, Agonist, and Constitutive Conformations.
    El Khamlichi C; Cobret L; Arrang JM; Morisset-Lopez S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Conformational Histamine H
    Schihada H; Ma X; Zabel U; Vischer HF; Schulte G; Leurs R; Pockes S; Lohse MJ
    ACS Sens; 2020 Jun; 5(6):1734-1742. PubMed ID: 32397705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRET: NanoLuc-Based Bioluminescence Resonance Energy Transfer Platform to Monitor Protein-Protein Interactions in Live Cells.
    Mo XL; Fu H
    Methods Mol Biol; 2016; 1439():263-71. PubMed ID: 27317001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding kinetics at histamine H
    Reiner D; Stark H
    Eur J Pharmacol; 2019 Apr; 848():112-120. PubMed ID: 30703360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of seven human histamine H
    Gao M; Dekker ME; Leurs R; Vischer HF
    Eur J Pharmacol; 2024 Apr; 968():176450. PubMed ID: 38387718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of histamine H
    Łażewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2018 Mar; 28(3):175-196. PubMed ID: 29334795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.
    White CW; Johnstone EKM; See HB; Pfleger KDG
    Cell Signal; 2019 Feb; 54():27-34. PubMed ID: 30471466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent Inhibition of the Histamine H
    Wágner G; Mocking TAM; Kooistra AJ; Slynko I; Ábrányi-Balogh P; Keserű GM; Wijtmans M; Vischer HF; de Esch IJP; Leurs R
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
    Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice.
    Nuutinen S; Mäki T; Rozov S; Bäckström P; Hyytiä P; Piepponen P; Panula P
    Neuropharmacology; 2016 Jul; 106():156-63. PubMed ID: 26107118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The luminescent HiBiT peptide enables selective quantitation of G protein-coupled receptor ligand engagement and internalization in living cells.
    Boursier ME; Levin S; Zimmerman K; Machleidt T; Hurst R; Butler BL; Eggers CT; Kirkland TA; Wood KV; Friedman Ohana R
    J Biol Chem; 2020 Apr; 295(15):5124-5135. PubMed ID: 32107310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid kinetic BRET measurements to monitor G protein activation by GPCR and non-GPCR proteins.
    Maziarz M; Garcia-Marcos M
    Methods Cell Biol; 2017; 142():145-157. PubMed ID: 28964333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NanoBRET-Based H
    Ma X; Gao M; Vischer HF; Leurs R
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms.
    Yan H; Zhang X; Hu W; Ma J; Hou W; Zhang X; Wang X; Gao J; Shen Y; Lv J; Ohtsu H; Han F; Wang G; Chen Z
    Nat Commun; 2014 Feb; 5():3334. PubMed ID: 24566390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes.
    Borroto-Escuela DO; Flajolet M; Agnati LF; Greengard P; Fuxe K
    Methods Cell Biol; 2013; 117():141-64. PubMed ID: 24143976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
    Le S; Gruner JA; Mathiasen JR; Marino MJ; Schaffhauser H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):902-9. PubMed ID: 18305012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.